TY - JOUR
T1 - Points of control exerted along the macrophage-endothelial cell-polymorphonuclear neutrophil axis by PECAM-1 in the innate immune response of acute colonic inflammation
AU - Sugimoto, Naohito
AU - Rui, Tao
AU - Yang, Min
AU - Bharwani, Sulaiman
AU - Handa, Osamu
AU - Yoshida, Norimasa
AU - Yoshikawa, Toshikazu
AU - Kvietys, Peter R.
PY - 2008/8/1
Y1 - 2008/8/1
N2 - PECAM-1 is expressed on endothelial cells and leukocytes. Its extracellular domain has been implicated in leukocyte diapedesis. In this study, we used PECAM-1-/- mice and relevant cells derived from them to assess the role of PECAM-1 in an experimental model of acute colonic inflammation with a predominant innate immune response, i.e., 2,4,6-trinitrobenzine sulfonic acid (TNBS). Using chimeric approaches, we addressed the points of control exerted by PECAM-1 along the macrophage-endothelial cell-polymorphonuclear neutrophil (PMN) axis. In vivo, TNBS-induced colitis was ameliorated in PECAM-1 -/- mice, an event attributed to PECAM-1 on hematopoietic cells rather than to PECAM-1 on endothelial cells. The in vivo innate immune response was mimicked in vitro by using a construct of the vascular-interstitial interface, i.e., PMN transendothelial migration was induced by colonic lavage fluid (CLF) from TNBS mice or macrophages (MΦ) challenged with CLF. Using the construct, we confirmed that endothelial cell PECAM-1 does not play a role in PMN transendothelial migration. Although MΦ activation (NF-κB nuclear binding) and function (keratinocyte-derived chemokine production) induced by CLF was diminished in PECAM-1-/- MΦ, this did not affect their ability to promote PMN transendothelial migration. By contrast, PECAM-1-/- PMN did not adhere to or migrate across endothelial cell monolayers in response to CLF. Further, as compared with PECAM-1+/+ PMN, PECAM-1-/- PMN were less effective in orientating their CXCR2 receptors (polarization) in the direction of a chemotactic gradient. Collectively, our findings indicate that PECAM-1 modulation of PMN function (at a step before diapedesis) most likely contributes to the inflammation in a colitis model with a strong innate immune component.
AB - PECAM-1 is expressed on endothelial cells and leukocytes. Its extracellular domain has been implicated in leukocyte diapedesis. In this study, we used PECAM-1-/- mice and relevant cells derived from them to assess the role of PECAM-1 in an experimental model of acute colonic inflammation with a predominant innate immune response, i.e., 2,4,6-trinitrobenzine sulfonic acid (TNBS). Using chimeric approaches, we addressed the points of control exerted by PECAM-1 along the macrophage-endothelial cell-polymorphonuclear neutrophil (PMN) axis. In vivo, TNBS-induced colitis was ameliorated in PECAM-1 -/- mice, an event attributed to PECAM-1 on hematopoietic cells rather than to PECAM-1 on endothelial cells. The in vivo innate immune response was mimicked in vitro by using a construct of the vascular-interstitial interface, i.e., PMN transendothelial migration was induced by colonic lavage fluid (CLF) from TNBS mice or macrophages (MΦ) challenged with CLF. Using the construct, we confirmed that endothelial cell PECAM-1 does not play a role in PMN transendothelial migration. Although MΦ activation (NF-κB nuclear binding) and function (keratinocyte-derived chemokine production) induced by CLF was diminished in PECAM-1-/- MΦ, this did not affect their ability to promote PMN transendothelial migration. By contrast, PECAM-1-/- PMN did not adhere to or migrate across endothelial cell monolayers in response to CLF. Further, as compared with PECAM-1+/+ PMN, PECAM-1-/- PMN were less effective in orientating their CXCR2 receptors (polarization) in the direction of a chemotactic gradient. Collectively, our findings indicate that PECAM-1 modulation of PMN function (at a step before diapedesis) most likely contributes to the inflammation in a colitis model with a strong innate immune component.
UR - http://www.scopus.com/inward/record.url?scp=49649121520&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=49649121520&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.181.3.2145
DO - 10.4049/jimmunol.181.3.2145
M3 - Article
C2 - 18641353
AN - SCOPUS:49649121520
SN - 0022-1767
VL - 181
SP - 2145
EP - 2154
JO - Journal of Immunology
JF - Journal of Immunology
IS - 3
ER -